JP2020500163A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020500163A5 JP2020500163A5 JP2019521018A JP2019521018A JP2020500163A5 JP 2020500163 A5 JP2020500163 A5 JP 2020500163A5 JP 2019521018 A JP2019521018 A JP 2019521018A JP 2019521018 A JP2019521018 A JP 2019521018A JP 2020500163 A5 JP2020500163 A5 JP 2020500163A5
- Authority
- JP
- Japan
- Prior art keywords
- ala
- controlled release
- gly
- preparation
- release preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023016292A JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662410748P | 2016-10-20 | 2016-10-20 | |
| US62/410,748 | 2016-10-20 | ||
| PCT/US2017/057606 WO2018075901A1 (en) | 2016-10-20 | 2017-10-20 | Methods of delivering a neuroprotective polypeptide to the central nervous system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023016292A Division JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020500163A JP2020500163A (ja) | 2020-01-09 |
| JP2020500163A5 true JP2020500163A5 (https=) | 2024-11-28 |
| JPWO2018075901A5 JPWO2018075901A5 (https=) | 2024-11-28 |
| JP7626362B2 JP7626362B2 (ja) | 2025-02-07 |
Family
ID=60382598
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019521018A Active JP7626362B2 (ja) | 2016-10-20 | 2017-10-20 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
| JP2023016292A Pending JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023016292A Pending JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11273130B2 (https=) |
| EP (2) | EP3528836A1 (https=) |
| JP (2) | JP7626362B2 (https=) |
| KR (2) | KR102687778B1 (https=) |
| CN (1) | CN110191717A (https=) |
| AU (1) | AU2017345724B2 (https=) |
| BR (1) | BR112019008021A2 (https=) |
| CA (1) | CA3040906A1 (https=) |
| MX (1) | MX2019004476A (https=) |
| SG (1) | SG11201903462UA (https=) |
| WO (1) | WO2018075901A1 (https=) |
| ZA (1) | ZA201902486B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110191717A (zh) | 2016-10-20 | 2019-08-30 | 佩特通公司 | 向中枢神经系统递送神经保护性多肽的方法 |
| BR112022001595A2 (pt) * | 2019-07-29 | 2022-03-22 | Peptron Inc | Composição farmacêutica para tratamento ou inibição da progressão da discinesia induzida por levodopa |
| EP4005587B1 (en) * | 2019-07-29 | 2026-03-18 | Peptron, Inc. | Pharmaceutical composition for treating levodopa-induced dyskinesia or for suppressing progression thereof |
| JP2023526512A (ja) * | 2020-05-22 | 2023-06-21 | トラスティーズ オブ ボストン ユニバーシティ | 線維化疾患を処置するための方法および組成物 |
| CN112014193B (zh) * | 2020-07-24 | 2021-06-15 | 武汉大学中南医院 | 一种新的fj染色方法和装置 |
| US11865213B2 (en) * | 2021-07-05 | 2024-01-09 | Mapi Pharma Ltd. | Semaglutide depot systems and use thereof |
| US12514908B2 (en) | 2021-07-05 | 2026-01-06 | Mapi Pharma Ltd. | Semaglutide depot systems and use thereof |
| CN116392576A (zh) * | 2023-05-26 | 2023-07-07 | 南通大学 | 一种gip受体激动剂在制备治疗脊髓损伤修复靶点药物中的应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US5609885A (en) | 1992-09-15 | 1997-03-11 | Alza Corporation | Osmotic membrane and delivery device |
| US6156331A (en) | 1996-02-02 | 2000-12-05 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| ES2233768T3 (es) | 1996-02-02 | 2005-06-16 | Alza Corporation | Liberacion prolongada de un agente activo utilizando un sistema implantable. |
| US6395292B2 (en) | 1996-02-02 | 2002-05-28 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| US6132420A (en) | 1996-02-02 | 2000-10-17 | Alza Corporation | Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems |
| US6261584B1 (en) | 1996-02-02 | 2001-07-17 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| ZA981610B (en) | 1997-03-24 | 1999-08-26 | Alza Corp | Self adjustable exit port. |
| MY125849A (en) | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
| CA2299425A1 (en) | 1997-08-08 | 1999-02-18 | Amylin Pharmaceuticals, Inc. | Novel exendin agonist compounds |
| ATE383867T1 (de) | 1997-11-14 | 2008-02-15 | Amylin Pharmaceuticals Inc | Neuartige exendin agonisten |
| ES2182379T3 (es) | 1997-12-22 | 2003-03-01 | Alza Corp | Membrana de regulacion del regimen de liberacion para dispositivos de administracion controlada de farmacos. |
| JP4173635B2 (ja) | 1997-12-29 | 2008-10-29 | インターシア セラピューティクス，インコーポレイティド | 膜プラグ保持機構を有する浸透供給装置 |
| WO1999033449A1 (en) | 1997-12-30 | 1999-07-08 | Alza Corporation | Beneficial agent delivery system with membrane plug |
| JP4383674B2 (ja) | 1998-12-31 | 2009-12-16 | インターシア セラピューティクス，インコーポレイティド | 空間効率のよいピストンを有する浸透圧送達システム |
| CA2402637C (en) | 1999-12-21 | 2007-04-10 | Alza Corporation | Valve for osmotic devices |
| US7163688B2 (en) | 2001-06-22 | 2007-01-16 | Alza Corporation | Osmotic implant with membrane and membrane retention means |
| EP1411968B1 (en) | 2001-07-31 | 2008-09-17 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Glp-1 exendin-4 peptide analogs and uses thereof |
| MXPA05000224A (es) | 2002-06-26 | 2005-06-03 | Alza Corp | Piston de volumen eficiente, minimamente deformable, para sistemas de suministro osmotico de farmacos. |
| US7014636B2 (en) | 2002-11-21 | 2006-03-21 | Alza Corporation | Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel |
| ATE387236T1 (de) | 2003-03-31 | 2008-03-15 | Alza Corp | Osmotische pumpe mit mitteln zum ableiten des innendrucks |
| US20080318837A1 (en) * | 2003-12-26 | 2008-12-25 | Nastech Pharmaceutical Company Inc. | Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide |
| US20050175701A1 (en) | 2004-02-10 | 2005-08-11 | Alza Corporation | Capillary moderator for osmotic delivery system |
| WO2006014425A1 (en) | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
| US8168222B2 (en) * | 2004-09-07 | 2012-05-01 | Board Of Regents Of The University Of Nebraska | Amphiphilic polymer-protein conjugates and methods of use thereof |
| MX2008014870A (es) | 2006-05-30 | 2009-02-12 | Intarcia Therapeutics Inc | Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas. |
| EP2049081B1 (en) | 2006-08-09 | 2012-11-14 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
| KR100805208B1 (ko) * | 2007-03-27 | 2008-02-21 | 주식회사 펩트론 | 엑센딘 함유 서방성 제제 조성물, 엑센딘 함유 서방성미립구 및 이의 제조 방법 |
| HRP20130259T1 (hr) | 2007-04-23 | 2013-04-30 | Intarcia Therapeutics, Inc. | Suspenzijske formulacije inzulinotropnih peptida i njihove uporabe |
| SMT201700583T1 (it) | 2009-09-28 | 2018-01-11 | Intarcia Therapeutics Inc | Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario |
| US9259432B1 (en) * | 2011-01-31 | 2016-02-16 | Parminder J. S. Vig | Composition and methods for targeted delivery of a therapeutic compound to the brain or spinal cord of a subject for treatment of neurodegenerative diseases |
| US20140220134A1 (en) | 2011-06-24 | 2014-08-07 | Astrazeneca Pharamceuticals LP | Method for treating diabetes with extended release formulation of glp-1 receptor agonists |
| JP6226510B2 (ja) | 2012-01-27 | 2017-11-08 | キヤノン株式会社 | 画像処理システム、処理方法及びプログラム |
| ITMI20130325A1 (it) | 2013-03-05 | 2014-09-06 | Telecom Italia Spa | Metodo per misurare e monitorare il livello di accesso a dati personali generati da risorse di un dispositivo d'utente |
| JP2015192425A (ja) | 2014-03-28 | 2015-11-02 | 富士通株式会社 | デマンド収容変更順序決定方法、およびデマンド収容変更順序決定プログラム |
| US20170035856A1 (en) * | 2014-04-16 | 2017-02-09 | Shandong Luye Pharmaceutical Co., Ltd. | Exenatide-containing composition and preparation method therefor |
| CN110191717A (zh) | 2016-10-20 | 2019-08-30 | 佩特通公司 | 向中枢神经系统递送神经保护性多肽的方法 |
-
2017
- 2017-10-20 CN CN201780078697.6A patent/CN110191717A/zh active Pending
- 2017-10-20 EP EP17800650.8A patent/EP3528836A1/en not_active Withdrawn
- 2017-10-20 MX MX2019004476A patent/MX2019004476A/es unknown
- 2017-10-20 EP EP25181393.7A patent/EP4635569A3/en active Pending
- 2017-10-20 KR KR1020217022385A patent/KR102687778B1/ko active Active
- 2017-10-20 US US16/342,685 patent/US11273130B2/en active Active
- 2017-10-20 BR BR112019008021A patent/BR112019008021A2/pt unknown
- 2017-10-20 AU AU2017345724A patent/AU2017345724B2/en active Active
- 2017-10-20 WO PCT/US2017/057606 patent/WO2018075901A1/en not_active Ceased
- 2017-10-20 JP JP2019521018A patent/JP7626362B2/ja active Active
- 2017-10-20 KR KR1020197014421A patent/KR20190086460A/ko not_active Ceased
- 2017-10-20 SG SG11201903462UA patent/SG11201903462UA/en unknown
- 2017-10-20 CA CA3040906A patent/CA3040906A1/en active Pending
-
2019
- 2019-04-17 ZA ZA2019/02486A patent/ZA201902486B/en unknown
-
2021
- 2021-11-09 US US17/522,687 patent/US11771657B2/en active Active
-
2023
- 2023-02-06 JP JP2023016292A patent/JP2023065401A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020500163A5 (https=) | ||
| EP2134329B1 (en) | Composition and microsphere for controlled-release of exendin, and method of preparing the same | |
| Lacroix et al. | The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations | |
| CA2320371A1 (en) | Inotropic and diuretic effects of exendin and glp-1 | |
| JP7626362B2 (ja) | 中枢神経系に神経保護ポリペプチドを送達する方法 | |
| US20010007853A1 (en) | Method for administering monomeric insulin analogs | |
| CN101588789B (zh) | 用于治疗牛和其它动物炎症的药物组合物和方法 | |
| CN102088997A (zh) | 用于治疗糖尿病和其他慢性疾病的组合物 | |
| WO2000047203A1 (en) | Formulation and system for intra-oral delivery of pharmaceutical agents | |
| MX2008016254A (es) | Uso de agonistas del receptor de adenosina a2a en el tratamiento de isquemia. | |
| CN103732215B (zh) | 组合肽纳米颗粒及掺入其的递送系统 | |
| US20120301535A1 (en) | Combination peptide-nanoparticles and delivery systems incorporating same | |
| US20130137670A1 (en) | Zwitterion solution for low-volume therapeutic delivery | |
| Minchin et al. | Pulmonary toxicity of doxorubicin administered by in situ isolated lung perfusion in dogs | |
| WO2022046976A1 (en) | An epinephrine injection formulation with very low epinephrine concentration and low impurities during its shelf-life | |
| WO2019193417A1 (en) | Composition and method of reducing joint pain associated with hemarthrosis | |
| Banerjee et al. | A novel peptide nanomedicine for treatment of pancreatogenic diabetes | |
| US9161910B2 (en) | Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type II diabetes | |
| Himori et al. | Assessment of the selectivity of OPC-2009, a new β2-adrenoceptor stimulant, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog | |
| JPWO2022056392A5 (https=) | ||
| US20050004221A1 (en) | Intrathecal gabapentin compositions | |
| CN121773127A (zh) | 用于治疗人类疾病和病症的稳定glp-1类似物 | |
| US20240108573A1 (en) | Nanolipid carrier based formulation for brain delivery through intranasal route and its preparation process | |
| JP2021512061A (ja) | ウリジンの全身送達のための組成物及びデバイス | |
| Demmy et al. | Resuscitation of injured myocardium with adenosine and biventricular assist |